EVIO, Inc. (EVIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
Mar 27, 2026, 10:11 AM EST
EVIO, Inc. Revenue
In the fiscal year ending September 30, 2021, EVIO, Inc. had annual revenue of $2.36M, down -34.29%. EVIO, Inc. had revenue of $603.19K in the quarter ending June 30, 2020, a decrease of -45.23%.
Revenue
2.36M
Revenue Growth
-39.96%
P/S Ratio
0.01
Revenue / Employee
131.28K
Employees
18
Market Cap
20.73K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2021 | 2.36M | -1.23M | -34.29% |
| Sep 30, 2020 | 3.60M | -193.82K | -5.11% |
| Sep 30, 2019 | 3.79M | 424.29K | 12.61% |
| Sep 30, 2018 | 3.37M | 344.50K | 11.40% |
| Sep 30, 2017 | 3.02M | 2.46M | 438.55% |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan General Group (China) | 80.38M |
| Marijuana Company of America | 1.50M |
| Veritas Farms | 883.65K |
| Aeolus Pharmaceuticals | 771.00K |
| ANBC, INC. | 50.95K |
| AREV Life Sciences Global | 5.33K |